Cancer Biology & Medicine （CBM） is a peer-reviewed open-access journal sponsored by China Anti-cancer Association (CACA) and Tianjin Medical University Cancer Institute and Hospital. The journal monthly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics:
- Cancer genetics
- Cancer and stem cell biology
- Molecular and clinical immunology
- Cancer prevention and epidemiology
- Cancer biomarkers
- Radiation oncology
- Oncology clinical trials
- Mechanisms of drug sensitivity and resistance
- Targeted therapy and immunotherapy
-
Multidisciplinary treatment and personalized medicine
CBM adheres to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors (ICMJE) and the guidelines of Commitee on Publication Ethics (COPE). The journal is indexed in SCOPUS, MEDLINE and SCI (IF 5.347, 5 year IF 6.624), with all full texts freely visible to clinicians and researchers all over the world (http://www.ncbi.nlm.nih.gov/pmc/journals/2000/).